Glenn HearsonMay 24, 2021Published StudyMore positive results from #ANDHI study for Benralizumab in Severe Eosinophilic AsthmaThe #ANDHI study, has recently had more results published in the European Journal of Allergy and Clinical Immunology "Benralizumab...
Glenn HearsonApr 1, 2021Latest ResearchNottingham Asthma Centre Newsletter: Spring 2021The Spring 2021 Asthma Newsletter is now out.
Glenn HearsonMar 24, 2021Recruiting StudyA year ago today NUH recruited their 1st patient into the worlds biggest #Covid19 treatment trialIt was one year ago today that Nottingham University Hospitals, using teams including those from the NIHR Nottingham BRC and...
Glenn HearsonJan 2, 2021Published StudyBenralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
Glenn HearsonNov 17, 2020Recruiting StudyAPEX Asthma Exacerbation Studies NewsletterOur APEX research studies looking into asthma attacks (exacerbations) new newsletter is now available. The APEX Studies are investigating...
Glenn HearsonNov 9, 2020Latest ResearchPONENTE study hits the mark in phase IIIb asthma trialPONENTE Phase IIIb open-label Fasenra (benralizumab)
Glenn HearsonOct 5, 2020Recruiting StudyThe Nottingham Recovery from COVID-19 Research Platform Assessment ClinicThe Nottingham Recovery from COVID-19 Research Platform Assessment Clinic
Glenn HearsonAug 1, 2020COVID-19Dexamethasone in Hospitalized Patients with Covid-19 Preliminary ReportDexamethasone in Hospitalized Patients with Covid-19 Preliminary Report